Page de couverture de Psychedelic Capital

Psychedelic Capital

Auteur(s): Ross O'Brien
Écouter gratuitement

  • Résumé

  • Join us for in-depth interviews with leading investors, entrepreneurs, researchers, and policymakers, pioneering a new future and healthcare with your host, Ross O'Brien, founder of Venture Capital firm, Bonaventure Venture Equity, author and lifelong entrepreneur. As an early investor in this new frontier, it's Ross's goal to share with you the conversations that he's having on an ongoing basis with the thought leaders and pioneers at this defining moment. We are in the midst of a mental health crisis, and an addiction crisis. Pain is an epidemic, and for the first time, we now have the legal pathways to develop psychedelic science to bring a new paradigm in medicine to the patients who need it most. As we imagine this new future, Ross is inspired every day by these visionaries and excited and privileged to introduce them to you.
    2023 | Psychedelic Capital
    Voir plus Voir moins
Épisodes
  • Navigating Regulatory Challenges and Ensuring Safety in the Psychedelics Industry

    Navigating Regulatory Challenges and Ensuring Safety in the Psychedelics Industry
    Aug 26 2023

    "Balancing Medical Promise and Regulatory Complexity in the Psychedelics Landscape"

    The "Psychedelics Capital Podcast" host Ross O'Brien  from Bonaventure Equity interviews Michael Werner from Holland & Knight, discussing the regulatory landscape for psychedelics. Michael, a partner at the law firm, explains that while the FDA sees itself as a public health agency focused on ensuring safe and effective products, the DEA approaches controlled substances like psychedelics from a law enforcement perspective due to their potential dangers. He highlights that while many drugs, including psychedelics, have potential benefits, the FDA emphasizes the importance of rigorous clinical trials to establish their safety and efficacy, particularly in a landscape where recreational and unregulated use is also prevalent.

     

    Produced by PodConx

    Ross O'Brien -  https://www.linkedin.com/in/rossobrien/

    Bonaventure Equity - https://link.bve.vc/Visit-Us

    Michael Warner - https://www.linkedin.com/in/michael-werner-a402189/

    Holland & Knight - https://www.hklaw.com/
    Voir plus Voir moins
    55 min
  • Unleashing the Power of Psychedelics and AI: Revolutionizing Mental Health with Sensorium Therapeutics

    Unleashing the Power of Psychedelics and AI: Revolutionizing Mental Health with Sensorium Therapeutics
    Jul 6 2023

    Exploring the Potential of Psychedelics and Natural Compounds

    Dick Simon, the founder of Sensorium Therapeutics, discusses his journey and motivation in the field of psychedelics. Inspired by a friend's success with psychedelics in treating mental health issues, Dick embarked on a mission to advance research and de-stigmatization. He he joins Ross O'Brien  from Bonaventure Equity to talk about  co-founding Sensorium to create novel pharmaceuticals using a comprehensive database of psychoactive plants and fungi, leveraging artificial intelligence and machine learning for drug discovery. The company aims to have a significant impact in mental health and provide alternative treatment options for those who may not benefit from traditional psychedelics therapies.

    Produced by PodConx

    Ross O'Brien -  https://www.linkedin.com/in/rossobrien/

    Bonaventure Equity - https://link.bve.vc/Visit-Us

    Dick Simons - https://www.linkedin.com/in/dick-simon-6050ba5/

    Sensorium Therapeutics - https://www.sensorium.bio/

     
    Voir plus Voir moins
    25 min
  • Cliché Busting: Navigating the Legal Challenges of the Cannabis and Psychedelic Industries

    Cliché Busting: Navigating the Legal Challenges of the Cannabis and Psychedelic Industries
    Mar 30 2023

    Jennifer Fisher and Bill Growney, two partners at Goodwin Proctor, a law firm specializing in the cannabis industry join Ross O'Brien  from Bonaventure Equity to talk about their practice and their work advising companies in the cannabis and psychedelic spaces. The conversation covers topics such as regulatory compliance, legal challenges, and unique challenges faced by emerging companies in these industries.

     

    Produced by PodConX

    Ross O'Brien -  https://www.linkedin.com/in/rossobrien/

    Bonaventure Equity - https://link.bve.vc/Visit-Us

    Jennifer Fisher - https://www.linkedin.com/in/jennifer-briggs-fisher-14843a/

    Bill Growney - https://www.linkedin.com/in/billgrowney/

    Goodwin Proctor - https://www.goodwinlaw.com/en
    Voir plus Voir moins
    43 min
Troubles et maladies Médecine alternative Hygiene & Healthy Living
Voir plus Voir moins

Ce que les auditeurs disent de Psychedelic Capital

Moyenne des évaluations de clients

Évaluations – Cliquez sur les onglets pour changer la source des évaluations.

Évaluations sur Audible.ca

Évaluations sur Amazon.ca
Il n'y a pas encore de critiques pour ce titre.